244 related articles for article (PubMed ID: 31713028)
21. Development of Collagenase Treatment for Dupuytren Disease.
Badalamente MA; Hurst LC
Hand Clin; 2018 Aug; 34(3):345-349. PubMed ID: 30012294
[TBL] [Abstract][Full Text] [Related]
22. Use of resources and costs associated with the treatment of Dupuytren's contracture at an orthopedics and traumatology surgery department in Denia (Spain): collagenase clostridium hystolyticum versus subtotal fasciectomy.
Sanjuan Cerveró R; Franco Ferrando N; Poquet Jornet J
BMC Musculoskelet Disord; 2013 Oct; 14():293. PubMed ID: 24125161
[TBL] [Abstract][Full Text] [Related]
23. Recurrent Dupuytren's disease after fasciectomy and collagenase injection are histologically indistinguishable.
Sanjuan-Cervero R; Carrera-Hueso FJ; Vaquero-Perez M; Montaner-Alonso D
J Hand Surg Eur Vol; 2020 Jun; 45(5):508-512. PubMed ID: 31980000
[TBL] [Abstract][Full Text] [Related]
24. [Dupuytren's disease treatment].
Kornø MR; Søe N; Dahlin LB
Ugeskr Laeger; 2015 Mar; 177(11):. PubMed ID: 25786701
[TBL] [Abstract][Full Text] [Related]
25. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
Zhang P; Qin L
N Engl J Med; 2009 Dec; 361(26):2578-9; author reply 2579-80. PubMed ID: 20032329
[No Abstract] [Full Text] [Related]
26. Pain Associated With Treatment of Dupuytren Contracture With Collagenase Clostridium histolyticum.
Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P; Fikri-Benbrahim N; Franco-Ferrando N; Peimer CA
J Hand Surg Am; 2017 Feb; 42(2):e109-e114. PubMed ID: 28160905
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and safety of collagenase Clostridium histolyticum in Dupuytren's disease : an observational study in Belgium.
Verstreken F; Degreef I; Decramer A; Libberecht K; Vanhove W; Datco A; Vanhaecke J; Clermont D; Duerinckx J
Acta Orthop Belg; 2016 Aug; 82(2):397-404. PubMed ID: 27682305
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Dupuytren's Contracture With Collagenase: A Systematic Review.
Sandler AB; Scanaliato JP; Dennis T; Gonzalez Trevizo GA; Raiciulescu S; Nesti L; Dunn JC
Hand (N Y); 2022 Sep; 17(5):815-824. PubMed ID: 33478271
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of Dupuytren's disease using collagenase from Clostridium histolyticum].
Martín-Ferrero MÁ; Simón-Pérez C; Rodríguez-Mateos JI; García-Medrano B; Hernández-Ramajo R; Brotat-García M
Rev Esp Cir Ortop Traumatol; 2013; 57(6):398-402. PubMed ID: 24071041
[TBL] [Abstract][Full Text] [Related]
30. Skin Laceration in Collagenase Clostridium histolyticum Treatment for Dupuytren's Contracture.
Sanjuan-Cervero R; Carrera-Hueso FJ; Oliver-Mengual S; Ramon-Barrios MA; Peimer CA; Fikri-Benbrahim N
Orthop Nurs; 2018; 37(2):144-153. PubMed ID: 29570549
[TBL] [Abstract][Full Text] [Related]
31. One year follow-up after treatment with CCH for Dupuytren's disease: A prospective view.
Sanjuán-Cerveró R; Vazquez-Ferreiro P; Gómez-Herrero D; Carrera-Hueso FJ; Fikri-Banbrahim N
Rev Esp Cir Ortop Traumatol (Engl Ed); 2018; 62(6):448-457. PubMed ID: 29519629
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture.
Bainbridge C; Gerber RA; Szczypa PP; Smith T; Kushner H; Cohen B; Hellio Le Graverand-Gastineau MP
J Plast Surg Hand Surg; 2012 Sep; 46(3-4):177-83. PubMed ID: 22670890
[TBL] [Abstract][Full Text] [Related]
33. DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture.
Räisänen MP; Karjalainen T; Göransson H; Reito A; Kautiainen H; Malmivaara A; Leppänen OV
BMJ Open; 2018 Mar; 8(3):e019054. PubMed ID: 29599391
[TBL] [Abstract][Full Text] [Related]
34. Limited Fasciectomy Versus Collagenase Clostridium histolyticum for Dupuytren Contracture: A Propensity Score Matched Study of Single Digit Treatment With Minimum 5 Years of Telephone Follow-Up.
Gruber JS; Zhang D; Janssen SJ; Blazar P; Jupiter JB; Earp BE
J Hand Surg Am; 2021 Oct; 46(10):888-895. PubMed ID: 34275684
[TBL] [Abstract][Full Text] [Related]
35. Short-term efficacy and adverse effects of collagenase clostridium histolyticum injections, percutaneous needle fasciotomy and limited fasciectomy in the treatment of Dupuytren's contracture: a network meta-analysis of randomized controlled trials.
Obed D; Salim M; Schlottmann F; Bingoel AS; Panayi AC; Dastagir K; Vogt PM; Koenneker S
BMC Musculoskelet Disord; 2022 Oct; 23(1):939. PubMed ID: 36307837
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial.
Costas B; Coleman S; Kaufman G; James R; Cohen B; Gaston RG
BMC Musculoskelet Disord; 2017 Aug; 18(1):374. PubMed ID: 28854973
[TBL] [Abstract][Full Text] [Related]
37. Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren's cords: an exploratory study.
Coleman S; Gilpin D; Tursi J; Kaufman G; Jones N; Cohen B
BMC Musculoskelet Disord; 2012 Apr; 13():61. PubMed ID: 22540636
[TBL] [Abstract][Full Text] [Related]
38. A
Pess GM; Sundbom M; Wilson K; Lindqvist D; Dahlin LB
J Plast Surg Hand Surg; 2018 Oct; 52(5):301-306. PubMed ID: 30039732
[TBL] [Abstract][Full Text] [Related]
39. [Long-term experience with Collagenase Clostridium Histolyticum (CCH, Xiapex®) for the treatment of Dupuytren's contracture: lessons learned].
Neuwirth M; Kalt L; Pipam W; Rab M
Handchir Mikrochir Plast Chir; 2019 Feb; 51(1):38-44. PubMed ID: 30836418
[TBL] [Abstract][Full Text] [Related]
40. The Impact of Collagenase Clostridium histolyticum Introduction on Dupuytren Treatment Patterns in the United States.
Zhao JZ; Hadley S; Floyd E; Earp BE; Blazar PE
J Hand Surg Am; 2016 Oct; 41(10):963-968. PubMed ID: 27546441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
